Loading news...
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its annual and fourth quarter 2025 financial results on Thursday, March 5, 2026, at 8:30 a.m. Eastern Time (ET).
Toronto, Ontario--(Newsfile Corp. - December 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD$0.02 per outstanding common share of the Company ("Common Shares"), payable on January 21, 2026, to holders of record of Common Shares as of the close of business on December 23, 2025. This dividend is designated as an "eligible dividend" for Canadian income tax purposes.
CareRx Corporation ( CRRX:CA ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Puneet Khanna - CEO, President & Director Suzanne Brand - Chief Financial Officer Conference Call Participants Gireesh Seesankar - Bloom Burton & Co., Research Division Gary Ho - Desjardins Securities Inc., Research Division Justin Keywood - Stifel Nicolaus Canada Inc., Research Division Kyle McPhee - Cormark Securities Inc., Research Division Douglas W. Loe - Leede Financial Inc., Research Division Doug Cooper - Beacon Securities Limited, Research Division Presentation Operator Good morning, everyone, and welcome to the CareRx's Third Quarter 2025 Financial Results Conference Call.
Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the third quarter that ended September 30, 2025. Highlights for the Third Quarter of 2025 Average Beds Serviced 1 increased to 91,298 as of September 30, 2025.
Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2025 financial results on Tuesday, November 4, 2025, at 8:30 a.m. Eastern Time (ET).
Bed Growth Delivers Ending Bed Count 91,062 Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the second quarter ended June 30, 2025. "The addition of new beds in the second quarter marks the beginning of what we expect will be a period of attractive growth," said Puneet Khanna, President and Chief Executive Officer of CareRx.
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call, including a slide presentation, to discuss its second quarter 2025 financial results on Thursday, July 31, 2025, at 8:30 a.m. Eastern Time (ET).
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 10:30 a.m. Eastern Time (ET).
Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to discuss its fourth quarter 2024 financial results on Wednesday, March 5, 2025, at 8:30 a.m. Eastern Time (ET).
CareRx Corporation (TSX:CRRX) has reported its financial results for the fourth quarter ended December 31, 2022, during which a key success was winning a multi-year contract to provide pharmacy services to residents in multiple seniors living facilities in Atlantic Canada. "Our 2022 results reflect the exceptional progress we have made in growing our national presence and expanding our leadership position over the past three years," said David Murphy, president and chief executive officer of CareRx in the results statement.
Canaccord Genuity (TSX:CF, LSE:CF) analysts have reiterated their ‘Buy' rating for CareRx Corporation (TSX:CRRX) but reduced their price target after the Canadian healthcare company raised equity financing. CareRx announced on January 18 it completed a bought deal offering and closed the first tranche of a concurrent private placement for aggregate gross proceeds of around $12.1 million.
CareRx Corporation (TSX:CRRX) announced that it has completed its bought deal public offering and closed the first tranche of the concurrent private placement for aggregate gross proceeds of around $12.1 million. The Canadian healthcare company issued an aggregate of 2,998,000 shares under the offering, including 35,000 shares issued as a result of the partial exercise of the over-allotment option granted to the syndicate of underwriters led by Cormark Securities Inc, at a price of $2.70 per share for aggregate gross proceeds of approximately $8.1 million.
Long-term care pharmacy service provider CareRx Corporation (TSX:CRRX) has managed to withstand the macro challenges facing its business, according to analysts at Leede Jones Gable. The company posted a significant jump in its third-quarter revenue, which was driven by acquisitions and organic growth from new contracts.